Gentian Diagnostics ASA — Earnings Release 2018

May 15, 2018

First Quarter Financial Report

First Quarter Financial Report

Moss, 15 May 2018

Gentian Diagnostics AS announces its results for the first quarter of 2018. The highlights include:

- Record level for total operating revenue of MNOK 11.2 for the quarter

- 100% growth in sales revenue compared to 1Q17

- 24 % growth in sales revenue compared to 4Q17

- Strong sales for both Cystatin C and fCal

- New Proof-of-Concept announced post end of quarter

Please find the report enclosed. The report will also be made available on www.gentian.no.

For further information, please contact:

Bård Sundrehagen

CEO, Gentian Diagnostics

E-mail: bard.sundrehagen@gentian.no

Cell Phone: +47 924 14 117

Njaal Kind

CFO, Gentian Diagnostics

E-mail: njaal.kind@gentian.no

Cell Phone. +47 919 06 525